336 related articles for article (PubMed ID: 28859669)
1. Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1).
Gu Y; Zhang Z; Yin J; Ye J; Song Y; Liu H; Xiong Y; Lu M; Zheng G; He Z
J Exp Clin Cancer Res; 2017 Aug; 36(1):114. PubMed ID: 28859669
[TBL] [Abstract][Full Text] [Related]
2. DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through
Vera O; Jimenez J; Pernia O; Rodriguez-Antolin C; Rodriguez C; Sanchez Cabo F; Soto J; Rosas R; Lopez-Magallon S; Esteban Rodriguez I; Dopazo A; Rojo F; Belda C; Alvarez R; Valentin J; Benitez J; Perona R; De Castro J; Ibanez de Caceres I
Theranostics; 2017; 7(17):4118-4134. PubMed ID: 29158814
[TBL] [Abstract][Full Text] [Related]
3. TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer.
Jia X; Zhang Z; Luo K; Zheng G; Lu M; Song Y; Liu H; Qiu H; He Z
Sci Rep; 2017 Jun; 7(1):3744. PubMed ID: 28623290
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
[TBL] [Abstract][Full Text] [Related]
5. Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin.
Li N; Liu Y; Pang H; Lee D; Zhou Y; Xiao Z
Med Sci Monit; 2019 Mar; 25():1590-1599. PubMed ID: 30821276
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
Cheng MW; Shen ZT; Hu GY; Luo LG
Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell.
Li N; Zhang F; Li S; Zhou S
Biochem Biophys Res Commun; 2014 Feb; 444(4):611-6. PubMed ID: 24486548
[TBL] [Abstract][Full Text] [Related]
9. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
Kang N; Choi SY; Kim YK; Yoo IeR; Han DH; Lee DS; Kim YS; Hong SH; Kang JH; Lee KY; Park JK; Sung SW; Park MS; Yim HW; Kim SJ; Park JY
Lung Cancer; 2015 Aug; 89(2):99-103. PubMed ID: 26101014
[TBL] [Abstract][Full Text] [Related]
10. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.
Sui C; Meng F; Li Y; Jiang Y
J Transl Med; 2015 Apr; 13():132. PubMed ID: 25927928
[TBL] [Abstract][Full Text] [Related]
11. Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters.
Wu Q; Yang Z; Xia L; Nie Y; Wu K; Shi Y; Fan D
Oncotarget; 2014 Nov; 5(22):11552-63. PubMed ID: 25344911
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
13. DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21
Xu S; Huang H; Chen YN; Deng YT; Zhang B; Xiong XD; Yuan Y; Zhu Y; Huang H; Xie L; Liu X
Cell Cycle; 2016 Nov; 15(21):2920-2930. PubMed ID: 27559850
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1.
Pei K; Zhu JJ; Wang CE; Xie QL; Guo JY
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4697-4704. PubMed ID: 27906433
[TBL] [Abstract][Full Text] [Related]
15. Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1).
Peng B; Yi S; Gu Y; Zheng G; He Z
Protein Expr Purif; 2012 Apr; 82(2):360-7. PubMed ID: 22365988
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.
El-Awady RA; Hersi F; Al-Tunaiji H; Saleh EM; Abdel-Wahab AH; Al Homssi A; Suhail M; El-Serafi A; Al-Tel T
Cancer Biol Ther; 2015; 16(7):1056-70. PubMed ID: 25962089
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2.
Xie J; Yu F; Li D; Zhu X; Zhang X; Lv Z
Tumour Biol; 2016 Jan; 37(1):1197-204. PubMed ID: 26282001
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
Yang C; Cai J; Wang Q; Tang H; Cao J; Wu L; Wang Z
Gynecol Oncol; 2012 Feb; 124(2):325-34. PubMed ID: 22005523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
